UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 298

Sortiert nach

Pathways to aggression in schizophrenia affect results of treatment

Schizophrenia bulletin, 2011-09, Vol.37 (5), p.921-929

2011

Volltextzugriff (PDF)

Unreliable conspiracies: survey results about COVID-19 conspiracy theories lack temporal stability

European psychiatry, 2023-03, Vol.66 (S1), p.S813-S813

2023

Volltextzugriff (PDF)

Changes of ambulance departures to assaults during COVID-19 pandemic restrictions

European psychiatry, 2022-06, Vol.65 (S1), p.S519-S519

2022

Volltextzugriff (PDF)

Heterogeneity of violence in schizophrenia and implications for long-term treatment

International journal of clinical practice (Esher), 2008-08, Vol.62 (8), p.1237-1245

2008

Volltextzugriff (PDF)

ITAREPS relapse prevention in schizophrenia

International journal of clinical practice (Esher), 2008-12, Vol.62 (12), p.1824-1825

Volavka, J.

2008

Volltextzugriff (PDF)

Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies

European psychiatry, 2016-01, Vol.31, p.13-19

2016

Volltextzugriff (PDF)

Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol on Hostility Among Patients With Schizophrenia

Psychiatric services (Washington, D.C.), 2001-11, Vol.52 (11), p.1510-1514

2001

Volltextzugriff (PDF)

Handbook of treatment‐resistant schizophrenia By LeslieCitrome. Published by Springer Healthcare, London, UK, 201366 pp., ISBN 978‐1‐908517‐86‐9

Acta psychiatrica Scandinavica, 2013-07, Vol.128 (1), p.102-102

Volavka, J.

2013

Volltextzugriff (PDF)

Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior

Molecular psychiatry, 1999-07, Vol.4 (4), p.385-388

1999

Volltextzugriff (PDF)

The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes

Neuropsychopharmacology (New York, N.Y.), 2004-11, Vol.29 (11), p.1943-1961

2004

Volltextzugriff (PDF)

Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism

Molecular psychiatry, 1999-05, Vol.4 (3), p.286-289

1999

Volltextzugriff (PDF)

The neurobiology of violence: an update

The journal of neuropsychiatry and clinical neurosciences, 1999, Vol.11 (3), p.307-314

Volavka, J

1999

Volltextzugriff (PDF)

Catecholamines and Aggression: The Role of COMT and MAO Polymorphisms

Annals of the New York Academy of Sciences, 2004-12, Vol.1036 (1), p.393-398

2004

Volltextzugriff (PDF)

Effect of risperidone on hostility in schizophrenia

Journal of clinical psychopharmacology, 1995-08, Vol.15 (4), p.243-249

1995

Volltextzugriff (PDF)

P.3.c.065 Comparison of multifactor dimensionality reduction (MDR) and neural network analysis: serotonergic system genes and antipsychotic response

European neuropsychopharmacology, 2010, Vol.20, p.S495-S496

2010

Volltextzugriff (PDF)

The effects of clozapine on aggression and substance abuse in schizophrenic patients

The journal of clinical psychiatry, 1999, Vol.60 Suppl 12, p.43

Volavka, J

1999

Volltextzugriff (PDF)

ITAREPS relapse prevention in schizophrenia: Editorials

International journal of clinical practice (Esher), 2008-12, Vol.62 (12), p.1824-1825

Volavka, J.

2008

Volltextzugriff (PDF)

Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics

The American journal of psychiatry, 2003-02, Vol.160 (2), p.290-296

2003

Volltextzugriff (PDF)

VIOLENT PATIENTS IN THE EMERGENCY SETTING

The Psychiatric clinics of North America, 1999-12, Vol.22 (4), p.789-801

1999

Volltextzugriff (PDF)

Suicidal behavior in patients with schizophrenia is related to COMT polymorphism

Psychiatric genetics, 2000-09, Vol.10 (3), p.117-124

2000

Volltextzugriff (PDF)

P03-04 Genomics, transcriptomics and methylomics: Alternative approaches for the analysis of serotonin system and antipsychotic response

European psychiatry, 2009, Vol.24, p.S1003-S1003

2009

Volltextzugriff (PDF)

Update on the biological treatment of aggression

Actas españolas de psiquiatría, 2006-03, Vol.34 (2), p.123

2006

Volltextzugriff (PDF)

Olanzapine for schizophrenia refractory to typical and atypical antipsychotics : an open-label, prospective trial

Journal of clinical psychopharmacology, 2001-08, Vol.21 (4), p.448-453

2001

Volltextzugriff (PDF)

Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder

The American journal of psychiatry, 2002-06, Vol.159 (6), p.1018-1028

2002

Volltextzugriff (PDF)

Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

The American journal of psychiatry, 2002-02, Vol.159 (2), p.255-262

2002

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(221)
Science & Technology
(197)
Life Sciences & Biomedicine
(195)
Psychiatry
(166)
Male
(127)
Adult
(121)
Biological And Medical Sciences
(97)
Female
(95)
Medical Sciences
(94)
Psychology. Psychoanalysis. Psychiatry
(84)
Schizophrenia - Drug Therapy
(73)
Middle Aged
(61)
Schizophrenic Psychology
(57)
Schizophrenia
(55)
Neurosciences & Neurology
(53)
Electroencephalography
(52)
Psychopathology. Psychiatry
(50)
Pharmacology. Drug Treatments
(49)
Antipsychotic Agents - Therapeutic Use
(47)
Neuropharmacology
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathways to aggression in schizophrenia affect results of treatment

Unreliable conspiracies: survey results about COVID-19 conspiracy theories lack temporal stability

Changes of ambulance departures to assaults during COVID-19 pandemic restrictions

Heterogeneity of violence in schizophrenia and implications for long-term treatment

ITAREPS relapse prevention in schizophrenia

Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies

Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol on Hostility Among Patients With Schizophrenia

Handbook of treatment‐resistant schizophrenia By LeslieCitrome. Published by Springer Healthcare, London, UK, 201366 pp., ISBN 978‐1‐908517‐86‐9

Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior

The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes

Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism

The neurobiology of violence: an update

Catecholamines and Aggression: The Role of COMT and MAO Polymorphisms

Effect of risperidone on hostility in schizophrenia

P.3.c.065 Comparison of multifactor dimensionality reduction (MDR) and neural network analysis: serotonergic system genes and antipsychotic response

The effects of clozapine on aggression and substance abuse in schizophrenic patients

ITAREPS relapse prevention in schizophrenia: Editorials

Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics

VIOLENT PATIENTS IN THE EMERGENCY SETTING

Suicidal behavior in patients with schizophrenia is related to COMT polymorphism

P03-04 Genomics, transcriptomics and methylomics: Alternative approaches for the analysis of serotonin system and antipsychotic response

Update on the biological treatment of aggression

Olanzapine for schizophrenia refractory to typical and atypical antipsychotics : an open-label, prospective trial

Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder

Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

Suchergebnisse filtern